Sonoran Biosciences Announces Qualified Infectious Disease Product (QIDP) Designation Granted by FDA for SBG003 for Surgical Site Infections in Abdominal Surgery TEMPE, Ariz., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Sonoran Biosciences (“Sonoran” or the “Company”, a preclinical-stage pharmaceutical company developing innovative hospital based products for the...